Based on the Savara Inc stock forecast from 6 analysts, the average analyst target price for Savara Inc is USD 9.07 over the next 12 months. Savara Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Savara Inc is Bearish, which is based on 1 positive signals and 5 negative signals. At the last closing, Savara Inc’s stock price was USD 3.47. Savara Inc’s stock price has changed by +10.86% over the past week, -0.29% over the past month and -7.71% over the last year.
No recent analyst target price found for Savara Inc
No recent average analyst rating found for Savara Inc
Company Overview Savara Inc
Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. The company's lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase 3 development stage for the treatment of autoimmune pulmonary alveolar proteinosis. Savara Inc. is headquartered in Langhorne, Pennsylvania. Read Less
Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. The company's lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase 3 development stage for the treatment of autoimmune ...Read More
Frequently Asked Questions About Savara Inc (SVRA) Stock
Based on ratings from 6 analysts Savara Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bearish. The stock has 14 buy, sell and 1 hold ratings.
Unfortunately we do not have enough data on SVRA's stock to indicate if its a good dividend stock.
Based on targets from 6 analysts, the average taret price for SVRA is USD 9.07 over the next 12 months. The maximum analyst target price is USD 15 while the minimum anlayst target price is USD 5.
Unfortunately we do not have enough data on SVRA's stock to indicate if its overvalued.
The last closing price of SVRA's stock was USD 3.47.
The most recent market capitalization for SVRA is USD 0.58B.
Based on targets from 6 analysts, the average taret price for SVRA is projected at USD 9.07 over the next 12 months.
This means that SVRA's stock price may go up by +161.29% over the next 12 months.
We can't find any ETFs which contains Savara Inc's stock.
As per our most recent records Savara Inc has 37 Employees.
Savara Inc's registered address is 1717 Langhorne Newtown Road, Langhorne, PA, United States, 19047.
You can get more information about it from Savara Inc's website at https://www.savarapharma.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Superior Earnings Growth
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Highly leveraged
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.
Frequently Asked Questions About Savara Inc (SVRA) Stock
Based on ratings from 6 analysts Savara Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bearish. The stock has 14 buy, sell and 1 hold ratings.
Unfortunately we do not have enough data on SVRA's stock to indicate if its a good dividend stock.
Based on targets from 6 analysts, the average taret price for SVRA is USD 9.07 over the next 12 months. The maximum analyst target price is USD 15 while the minimum anlayst target price is USD 5.
Unfortunately we do not have enough data on SVRA's stock to indicate if its overvalued.
The last closing price of SVRA's stock was USD 3.47.
The most recent market capitalization for SVRA is USD 0.58B.
Based on targets from 6 analysts, the average taret price for SVRA is projected at USD 9.07 over the next 12 months.
This means that SVRA's stock price may go up by +161.29% over the next 12 months.
We can't find any ETFs which contains Savara Inc's stock.
As per our most recent records Savara Inc has 37 Employees.
Savara Inc's registered address is 1717 Langhorne Newtown Road, Langhorne, PA, United States, 19047.
You can get more information about it from Savara Inc's website at https://www.savarapharma.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for SVRA !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
